Core Wealth Advisors (Florida)’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-200
Closed -$9.7K 227
2024
Q1
$9.7K Hold
200
﹤0.01% 192
2023
Q4
$10.7K Hold
200
﹤0.01% 180
2023
Q3
$11.7K Hold
200
﹤0.01% 144
2023
Q2
$12.6K Hold
200
0.01% 140
2023
Q1
$12.6K Hold
200
0.01% 138
2022
Q4
$10.6K Hold
200
﹤0.01% 152
2022
Q3
$11K Hold
200
0.01% 136
2022
Q2
$14K Hold
200
0.01% 127
2022
Q1
$16K Hold
200
0.01% 130
2021
Q4
$20K Hold
200
0.01% 129
2021
Q3
$18K Hold
200
0.01% 116
2021
Q2
$20K Hold
200
0.01% 106
2021
Q1
$20K Hold
200
0.02% 97
2020
Q4
$15K Hold
200
0.01% 105
2020
Q3
$15K Hold
200
0.01% 90
2020
Q2
$15K Hold
200
0.01% 84
2020
Q1
$12K Hold
200
0.01% 85
2019
Q4
$16K Buy
+200
New +$14.7K 0.01% 81

Other funds holding USNA

Core Wealth Advisors (Florida)'s USNA Position: Q2 2024 in Review

Core Wealth Advisors (Florida) sold out of Usana Health Sciences (USNA) in Q2 2024, closing a stake of 200 shares — an estimated $9.7K sold.

Core Wealth Advisors (Florida) first reported a position in USNA in Q4 2019 and held it in 18 quarters. The position peaked at $20K in Q4 2021. 154 funds tracked by Wall St. Rank hold USNA as of Q2 2024.

  • Core Wealth Advisors (Florida) reported no remaining Usana Health Sciences position as of Q2 2024 after selling out during the quarter.
  • Core Wealth Advisors (Florida) sold 200 Usana Health Sciences shares in Q2 2024, an estimated $9.7K.
  • Core Wealth Advisors (Florida) first reported a position in Usana Health Sciences in Q4 2019 and held it in 18 quarters.
  • Core Wealth Advisors (Florida)'s Usana Health Sciences position peaked at $20K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2024.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2024, filed 15 Aug 2024.